help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Veldhuis, J. D.
Right arrow Articles by Steven M. Pincus,
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Veldhuis, J. D.
Right arrow Articles by Steven M. Pincus,
The Journal of Clinical Endocrinology & Metabolism Vol. 84, No. 10 3498-3505
Copyright © 1999 by The Endocrine Society


From the Clinical Research Centers

Disruption of the Young-Adult Synchrony between Luteinizing Hormone Release and Oscillations in Follicle-Stimulating Hormone, Prolactin, and Nocturnal Penile Tumescence (NPT) in Healthy Older Men1

Johannes D. Veldhuis, Ali Iranmanesh, Thomas Mulligan and Steven M. Pincus

Division of Endocrinology (J.D.V.), Department of Internal Medicine, National Science Foundation Center for Biological Timing, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908; Endocrine Section, Medicine Service (A.I.), Salem Veterans Affairs Medical Center, Salem, Virginia 24153; Geriatrics Medicine (T.M.), Hunter Holmes McGuire Veterans Affairs Medical Center, Richmond, Virginia 23249; Moose Hill Road (S.M.P.), Guilford, Connecticut 06437

Address correspondence and requests for reprints to: Division of Endocrinology, Department of Internal Medicine, Box 202, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908; E-mail: JDV{at}Virginia.Edu


    Abstract
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
The healthy human male hypothalamo-pituitary-gonadal axis exhibits age-dependent loss of coordinate LH-testosterone secretion. A putative independent defect in Leydig-cell steroidogenesis with aging would confound the attribution of such LH-testosterone asynchrony to a hypothalamo-pituitary locus per se. Accordingly, here we appraise by sampling every 2.5 min overnight the joint synchrony of moment-to-moment LH release with simultaneously monitored pituitary FSH secretion, prolactin release, and nocturnal penile tumescence (NPT) oscillations, as a neurophysiological correlate of sleep regulation) in 10 young (ages 21–34) and 8 older (ages 62–72) healthy men. Joint synchrony for paired LH-FSH, LH-prolactin, and LH-NPT observations in young vs. older individuals was quantified by the cross-approximate entropy (cross-ApEn) statistic, with larger cross-ApEn values indicating greater two-variable asynchrony. Concomitantly, we assessed (possible) univariate changes with age for each of LH, FSH, prolactin, and NPT, as quantified by approximate entropy (ApEn). Hormone assays were performed by random-access direct chemiluminescence analyzer. Overnight mean (±SEM) serum LH concentrations (IU/L) were equivalent in older (3.1 ± 0.31 IU/L) and younger (2.9 ± 0.29) men, as were their serum total testosterone concentrations; viz., 425 ± 48 (older) and 523 ± 40 (younger) ng/dL. However, all three sets of paired time-series were significantly more asynchronous in the older cohort. First, cross-ApEn of paired LH-FSH release was significantly higher (or more asynchronous) in older subjects; viz., 1.902 ± 0.022 in older men vs. 1.607 ± 0.058 in younger individuals (P = 0.0005). Second, cross-ApEn of paired LH and prolactin release was 1.744 ± 0.085 in older volunteers vs. 1.346 ± 0.084 in younger subjects (P = 0.0046). Third, and most notably, cross-ApEn for the joint LH-NPT observation time-series was significantly greater in older subjects at 1.771 ± 0.056 vs. 1.223 ± 0.086 (young) (P = 0.0001), thereby denoting loss of coordination between (neural) signals directing intermittent LH secretion and those governing sleep-associated penile tumescence in older men. Among one-variable results, only ApEn of LH release was significantly higher in older individuals at 1.323 ± 0.058 vs. 0.897 ± 0.089 in younger subjects (P = 0.0019), signifying greater disorderliness of the LH secretory process in aged men. Individual ApEn values of FSH and prolactin release and NPT were age-invariant.

In ensemble, the present clinical experiments indicate that, within the aging male reproductive axis, bihormonal network disruption is more pronounced than individual signal disruption. We suggest that abrogation of joint synchrony among hypothalamically directed pituitary hormones and a neurogenically organized sexual response (nocturnal penile tumescence) can be unified thematically under an hypothesis of disrupted central nervous system hypothalamo-pituitary network coordination in human aging. Such implicit disarray of multinodal communication is of consequence both scientifically and clinically, especially in proposing aging theories and intervention strategies.


    Introduction
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Healthy aging in the human is accompanied by erosion of the orderliness of the secretory patterns of multiple individual hormones; e.g. LH, testosterone, and GH in men, and insulin, ACTH, and cortisol in women and men (1, 2, 3, 4). In addition to such (univariate) disruption of time-ordered neurohormone release, the young-adult bihormonal synchrony between LH and testosterone secretion patterns deteriorates in the older male (1, 5, 6, 7), and the coupling between ACTH and cortisol secretion declines significantly in older women and men. Loss of joint (bivariate) hormonal secretion in aging could indicate disturbances in feedback and/or feedforward linkages within a neuroendocrine axis or failure of a single relevant control locus within the network (1, 8).

A notion of altered feedback/feedforward neuroendocrine interactions in mediating bihormonal asynchrony is supported by a number of clinical pathophysiological paradigms of control-signal withdrawal, as considered further in the Discussion section of this paper. Accordingly, pertinent statistical assessment of both one-variable irregularity and of two-variable asynchrony can potentially offer pivotal insights into altered network-level behavior within biological feedback systems (9).

Clinical investigations of the aging (human) male reproductive axis have disclosed alterations in both the pulsatile mode and the serial orderliness of LH secretion considered univariately (1, 10, 11, 12, 13). Pulsatile LH release in healthy older men tends to be marked by lower-amplitude and more frequent secretory events (10, 11, 12, 13). Concomitantly, LH secretion, as assessed by approximate entropy (ApEn), becomes significantly and consistently more irregular with advancing age in both men and women (1, 3, 12). Disruption of hypothalamic GnRH release may subserve both of these (pulsatile and nonpulatile) alterations in LH control, as pulsatile iv GnRH infusion for two weeks in older men restores LH pulsatility and entropy estimates to values equivalent to those achieved in similarly treated young adults (12). However, serum testosterone concentrations fail to rise significantly during GnRH infusion in older subjects (unlike in young men), which can be explicated by earlier studies in aging individuals showing diminished Leydig-cell steroidogenic reserve under short-term drive by human chorionic gonadotropin. Thus, clinical observations in older men point to at least two distinct functionally defective loci within the aging male hypothalamo-pituitary-gonadal axis: viz., diminished steroidogenic activity of testicular Leydig cells and impaired output of the GnRH-LH (hypothalamo-pituitary) unit.

Assuming that hypothalamo-pituitary and gonadal alterations coexist in aging men, then any interpretations of the basis for the previously reported loss of coupled LH-testosterone secretion in older subjects should include both attenuated Leydig-cell responsiveness to circulating LH and dysregulation of (hypothalamic) GnRH-directed LH secretion (1). Accordingly, here to evaluate more directly an hypothesis of loss of coordinated central neuroendocrine control of release of the hypothalamo-pituitary unit in older men, we assess pairwise synchrony of the pituitary hormones LH-FSH and LH-prolactin as well as joint LH-NPT oscillatory patterns in healthy older individuals compared with young counterparts. NPT was used as an integrated neurophysiological surrogate for central nervous system (CNS) sleep-wake regulation, as it is a strong correlate of REM sleep (14). Furthermore, and critically, we evaluate whether changes with this multihormonal axis with increasing age mechanistically reflect primarily disruption of the underlying network (e.g. pathway-dependent or central control aspects), or mirror alterations in specific nodal (individual hormone release) characteristics. As suitable analytic strategies to quantify the notions under investigation, we assess changes in joint variable asynchrony (conditional irregularity) via cross-approximate entropy (cross-ApEn) (1, 15), and we evaluate single-variable sequential irregularity by approximate entropy (ApEn) (15, 16), both described in Materials and Methods.


    Methods
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Clinical protocol

Healthy young men (n = 10, ages 21–34 yr) and older men (n = 8, ages 62–72 yr) were recruited from the Charlottesville, Richmond, and Salem Virginia communities for study in the General Clinical Research Center (GCRC) at the University of Virginia Health Sciences Center. After provision of written informed consent, each volunteer underwent one night of prior adaptation in the GCRC. This was followed on a second night by blood sampling at 2.5-min intervals while sleeping (from 2300 clocktime, average sampling interval 7 h). A long nonthrombogenic catheter was used, from an adjacent room, to withdraw blood samples, to avoid disturbing the subject (1). Nocturnal penile tumescence (NPT) was monitored concurrently by recording penile circumference continuously (see below). No volunteer was receiving any systemic medications, had any acute or chronic illness, had undertaken recent transmeridian travel (across more than 3 time zones within 2 weeks), had experienced recent weight loss or gain (more than 2 kg in 10 days), or had any evidence by screening biochemical assessments, physical examination, or medical history of hepatic, renal, hematologic, metabolic, or endocrine disease. Baseline morning fasting serum concentrations of prolactin, LH, FSH, GH, TSH, IGF-I, thyroxine, resin T3 uptake, total testosterone, and estradiol were normal for age (2).

Assays

Serum LH, FSH, testosterone, and prolactin concentrations were assayed in each serum sample in an automated random-access chemiluminescence-based assay (ACS: 180, Chiron Corp. Diagnostic, Corp., Walpole, MA) in singlet. Independent studies demonstrated a strongly positive linear correlation between LH, FSH, testosterone, and prolactin concentrations measured by chemiluminescence and corresponding values obtained by RIA or immunoradiometric assays (all r >= + 0.873; P < 10-5, n = 18 samples) (2, 17). Reference standards were Second World Health Organization International Standards 80/552 and 94/6532 for LH and FSH, respectively. The within-assay coefficients of variation were less than 6.5%, and the between-assay coefficients of variation were less than 9.5%. All samples from an individual were analyzed together to eliminate interassay variability.

Calculation of sample LH secretion rates

For paired comparisons between LH and NPT time series, both untransformed serum LH concentrations and waveform-independent deconvolved LH secretion time series were used. The latter technique computes sample LH secretion rates without any assumptions regarding the form or amount of underlying basal or pulsatile LH release, by using a priori determined biexponential hormone kinetics (18). Here, we assumed an LH mean rapid-phase half-life of 18 min, a slower phase of 90 min, and a fractional amplitude (ratio of the slow component to the total amplitude) of 0.37, as determined directly earlier (19). The sample LH secretory rates or serum LH concentrations were then paired with 2.5-minutely (binned) NPT values (below).

Nocturnal penile tumescence (NPT)

NPT was monitored as a neurophysiological correlate of CNS sleep-wake regulation by continuous recordings of penile circumference via a strain gauge applied overnight, as described in other sleep studies (14). The subject was adapted to the monitoring device during an earlier night in the GCRC. Penile circumference was recorded in 30-second epochs, the values of which were averaged to yield 2.5-minutely bins for further analysis.

Approximate Entropy (ApEn) and Cross-ApEn

ApEn comprises a class of translation-, model- and scale-independent statistics designed to assess the pattern randomness or ad seriatim irregularity within a time series (16). ApEn quantifies the subpattern replicability or orderliness of successive measurements, which is not necessarily identified by pulse-detection algorithms (9). ApEn is a non-negative number calculated as an ensemble value for a data series (e.g. any given profile of serial hormone concentrations or sample secretion rates). Larger ApEn values denote greater randomness or less pattern reproducibility in the time series. Technically, ApEn quantifies the logarithmic likelihood that runs of patterns in the data that are similar remain similar on next incremental comparison. The formal definition of calculated ApEn is given in recent publications (8, 15). Briefly, for any given data series containing N observations two input parameters, namely m and r, are fixed to compute ApEn from vector sequences constructed from the serially observed data. Here, m represents the vector or window length of consecutive hormone measurements, and, r, the tolerance for testing subpattern regularity. To maintain scale invariance, r is typically defined as a percentage of the between-sample SD of each time series, e.g. 20%, and m as a value of 1 or 2 denoting consecutive vectors of length 1 or 2 data points. In the time series analyzed here, we calculated ApEn values with r = 20% and m = 1, and hence the designation, ApEn (1, 20%). This parameter set, standard in virtually all clinical applications, provides an appropriate ApEn statistic for assessing irregularity in data series of this length.

To quantify joint asynchrony (conditional irregularity), we used cross-ApEn, introduced in reference (15), definition 5. As noted there, cross-ApEn can be employed to compare sequences from two distinct yet intertwined variables in a network, herein applied to relevant pairs of hormonal time-series. The precise definition is thematically similar to that for ApEn (15). For this study, we applied cross-ApEn with m = 1 and r = 0.2 to standardized u-v time-series data; i.e., for each subject, we applied cross-ApEn(1,0.2) to the [u1(i), v1(i)] series, where u1(i) = (u(i)—mean u)/SD u and v1(i) = (v(i)—mean v)/SD v. To develop visual intuition, Figure 1Go of reference 9, taken from a recent study of paired ACTH-cortisol dynamics in Cushing’s disease, illustrates the cross-ApEn quantification and changes in the measure under pathophysiology.



View larger version (42K):
[in this window]
[in a new window]
 
Figure 1. Overnight serum LH (top-most panel), FSH (upper), and prolactin (lower) concentrations with concurrent NPT (bottom-most panel) profiles illustrated for one healthy young and older man. Hormone measurements were made by random-access, chemiluminescence-based automated assay after sampling blood every 2.5 min overnight. NPT was monitored continuously. Fitted curves for the hormone profiles were calculated by deconvolution analysis, as discussed in .Materials and Methods. Data from all ten young and eight older individuals are discussed in Results, and in Tables 2Go and 3Go.

 
ApEn and cross-ApEn evaluate subordinate as well as dominant patterns in data; thus, they quantify changes in underlying episodic behavior that do not reflect in peak occurrences or amplitudes. Also, ApEn and cross-ApEn are equally applicable to those (disordered) signals in which the notion of a particular feature such as a pulse is not even clear; e.g. testosterone time-series in older males (1), and both LH and particularly FSH series (3). Moreover, for many empirical data sets and for complicated, composite models, ApEn and cross-ApEn more clearly quantify time-series distinctions than do spectral and correlation assessments (both univariate and bivariate). This issue is more thoroughly and theoretically discussed in the Appendix to reference 1. Thematically, data sets with broad-banded spectra with few sharp peaks pose the most pronounced statistical challenges to spectral and correlation methods, for the purpose of discrimination. This is illustrated in reference 1, in which older subjects had highly significantly greater cross-ApEn (LH-t) values than did younger subjects, while no significant LH-T linear correlation (Pearson "R") differences were found between the younger and older cohorts.

To establish statistical replicability of ApEn and cross-ApEn with the specified parameter choices m = 1, r = 20% SD, standard deviation calculations have previously been performed for these measures, via extensive Monte Carlo calculations. It was established that 1 SD of ApEn and cross-ApEn with these parameter choices, for data lengths N > 100 points, is less than 0.06 for wide classes of diverse mathematical models, encompassing both orderly (regular) and highly disorderly time-series settings (15, 16, 20). It is this small standard deviation of ApEn and cross-ApEn, that provides its usefulness, via good reproducibility, to time-series data analysis as performed herein.

Further technical discussion of mathematical and statistical properties of ApEn and cross-ApEn, including robustness to noise and artifacts, mesh interplay, relative consistency of (m, r) pair choices, asymptotic normality under general assumptions, statistical bias, and error estimation for general processes can be found elsewhere (16).

For ApEn and cross-ApEn calculations involving NPT, the original 30-sec NPT data were averaged across 2.5-minutely epochs. To maintain equal values of N (series lengths), all comparisons were carried out for overnight sampling data beginning at sleep onset recorded by EEG (n = 178 sample observations).

Statistics

Statistical comparisons were made by two-tailed unpaired Student’s t tests.


    Results
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Figure 1AGo illustrates in one young and one older man 2.5-min sampled overnight serum LH, FSH, and prolactin concentrations and concomitant NPT profiles. Corresponding calculated (predicted) secretory or smoothed NPT profiles are denoted by continuous lines to represent the deconvolution fits (21).

Overnight mean serum LH concentrations (IU/L) were similar in older and young men, as were serum (total) testosterone concentrations: Table 1Go. The overnight mean serum FSH concentration was higher in older men, whereas that of prolactin was reduced (Table 1Go).


View this table:
[in this window]
[in a new window]
 
Table 1. Selected sperm hormone concentrations in young and older men

 
As summarized in Table 2Go, the mean (unvariate) ApEn values for overnight serum LH concentration time series were significantly elevated in older (n = 8) compared with young (n = 10) individuals, thereby affirming greater disorderliness of LH release in older men (P = 0.0019). Mean univariate ApEn values for overnight testosterone, FSH, prolactin, and NPT time series in older men were not different from corresponding values in young individuals.


View this table:
[in this window]
[in a new window]
 
Table 2. Univariate approximate entropy (ApEn) values of overnight hormone release or NPT oscillations in young and older men

 
Cross-ApEn values in the young and older cohorts are given in Figs. 2Go, 3Go, and 4Go and Table 3Go for bivariate (paired) LH-FSH, LH-prolactin, an FSH-prolactin serum concentration time series, and for paired LH concentration or LH secretory rate and NPT measurements. Figures 2–4GoGoGo display, respectively, the dispersion of individual subject cross-ApEn values for several of the foregoing sets of significant paired comparisons. In these joint comparisons, cross-ApEn was greater in the older cohort, marking greater asynchrony in the paired signals under consideration. We also confirm the earlier reported age-related increase in LH-testosterone irregularity (1), and note for the first time elevated testosterone-NPT cross-ApEn values in older men (Table 3Go).



View larger version (10K):
[in this window]
[in a new window]
 
Figure 2. Individual subject cross-ApEn (X-ApEn) values for the joint LH-FSH time-series in ten young and eight older men sampled every 2.5 min overnight. Higher cross-ApEn values denote greater joint series asynchrony in the older cohort.

 


View larger version (11K):
[in this window]
[in a new window]
 
Figure 3. Individual subject cross-ApEn (X-ApEn) values for joint LH-prolactin time-series in ten young and eight older men sampled every 2.5 min overnight. Data are presented in the format of Fig. 2Go.

 


View larger version (14K):
[in this window]
[in a new window]
 
Figure 4. Individual subject cross-ApEn (X-ApEn) values for the joint LH-concentration NPT (Panel A) or LH-secretion NPT (Panel B) time-series in ten young and eight healthy older men. Data are presented in the format of Fig. 2Go.

 

View this table:
[in this window]
[in a new window]
 
Table 3. Statistical comparisons of cross-approximate entropy (cross-ApEn) values in young and older men sampled overnight

 

    Discussion
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Aging in healthy men is marked by a gradual decline in anabolism, reduced physical stamina, and reproductive vigor (both potency and libido), and concomitant decrements in serum total, bioavailable, and free testosterone concentrations in most but not all cross-sectional studies, as well as in a recent longitudinal clinical investigation (10, 13, 22, 23, 24, 25, 26). The precise pathophysiological mechanisms that underlie the age-associated diminution in androgen output and the accompanying relative physical frailty are not well defined. Both hypoandrogenemia and the frailty of aging are exacerbated by comorbidity, such as acute or chronic illness, concurrent medications, weight loss, and/or uncompensated metabolic stress (27, 28, 29). The foregoing proclivity of male steroidogenic (Leydig-cell) activity to falter with age has been termed "andropause". According to one thesis, andropause has significant clinical implications to the aging-related reductions in physical (aerobic) capacity, diminution in muscular and skeletal mass, limitation in fertility, impairment in sexual function, and decline in psychological well being. The pathophysiological mechanisms subserving hypoandrogenemia in the aging male presumptively include both testicular failure and inappropriately restrained gonadotropin (particularly LH, and to a lesser degree FSH) secretion (1, 3, 10, 13, 14, 24, 25, 26, 30, 31). From an experimental perspective and from the vantage of scientific hypothesis testing, such dual defects would confound a facile interpretation of the earlier observed failure of coordinate LH-testosterone secretion in aging (1). Here, to evaluate a pivotal postulate of an aging-related true loss of central neuroendocrine coordination within the (older) male hypothalamo-pituitary unit, we assessed the joint synchrony of pituitary LH-FSH, LH-prolactin, and FSH-prolactin release, as well as paired LH-NPT observations. NPT was used as an integrated neurophysiological surrogate of CNS sleep-wake activity regulation (14). Analyses via the cross-approximate entropy (cross-ApEn) statistic unmasked an unequivocal contrast between young and older healthy men. Healthy older individuals evinced marked disruption of expected bihormonal pattern synchrony of paired (pituitary) time series, as well as of LH-NPT oscillations. Age-related abrogation of synchrony among these distinct hypothalamic-dependent processes likely articulates a loss of central multineuronal (network-like) coordination of the reproductive axis in the older male.

The presently quantified disruption of synchronous LH and prolactin, as well as LH and FSH release in older men could point to reduced hypothalamically directed coordination of moment-to-moment pituitary release of these glycoprotein-hormone pairs. We demonstrated similar asynchrony, albeit to a less vivid extent, for paired pituitary FSH and prolactin secretion, and confirmed the LH-testosterone asynchrony reported earlier in an older male cohort (1). Several important plausible mechanisms may underpin this erosion of pituitary (bihormonal) secretory-pattern synchrony. First, we speculate that aging impairs hypothalamic signaling of pituitary gonadotrope (LH- and FSH-secreting) and lactotroph (prolactin-secreting) cells. This could arise from altered neurotransmitter regulation of the arcuate-nucleus GnRH-neuronal ensemble, impaired median-eminence release of GnRH, or disrupted stimulation by other putative neuromodulators of LH, FSH, and prolactin secretion (32). A possible structural basis for such postulated dysregulation of GnRH secretion, as intimated by studies in the aged male virgin rat, is an age-related change in the density of multisynaptic inputs to hypothalamic GnRH neurons (33). Second, age-associated disturbances in intrapituitary autocrine and/or paracrine regulatory mechanisms could impose LH-prolactin asynchrony, e.g. as mediated via local intrahypophyseal effector release, e.g. {alpha}-subunit, which inter alia is postulated to link lactotroph and gonadotrope cellular activities (34, 35). Third, altered sex-steroid feedback sensitivity of the GnRH-gonadotrope unit may operate in older men and women (13, 36). Fourth, since NPT is a neurophysiological correlate of the CNS sleep-wake cycle (viz., NPT is associated preferentially with REM sleep) (14), the significant pattern linkage of NPT oscillations to LH secretion, as documented here in young men, likely reflects the physiological coupling of relevant CNS pathways that govern sleep-wake cycle activity with those that direct intermittent output of the GnRH neuronal ensemble. Accordingly, the loss of young-adult synchrony between LH (concentrations or secretory rates) and NPT oscillations evident in aging men points to declension of CNS-hypothalamic network control in older individuals, as schematically envisioned in Fig. 5Go. This hypothesis of disrupted CNS network communication is reinforced by the similar univariate NPT ApEn values in young and older men; i.e. there is preserved pattern orderliness of NPT oscillations in older individuals, despite potential age-associated changes in sleep architecture (14, 37). Consequently, impoverished joint LH-NPT synchrony, rather than disrupted orderliness of NPT patterns per se, may mark an early stage in the healthy aging process in men.



View larger version (41K):
[in this window]
[in a new window]
 
Figure 5. Schematized depiction of postulated interacting CNS-neuronal networks coordinating sleep-wake activity cycles, the neurogenically organized REM-associated signal NPT, GnRH pulse-generator output, and a (putative) prolactin (PRL) pulse organizer. Not shown are neurotransmitter pathways; (intra)pituitary endocrine, paracrine, or autocrine effectors; and possible hypothalamic feedback actions of prolactin.

 
Our inference of disrupted network-level control of the GnRH-LH-testosterone axis, based on ApEn and cross-ApEn, is affirmed further indirectly by analogy with other animal and human experiments using entropy and cross-entropy analyses. For example, treatment of healthy young men with the drug ketoconazole, which reversibly inhibits both adrenal and gonadal steroidogenesis (and thereby reduces the negative feedback exerted by testosterone), elicits marked increased disorderliness of LH release (38). Reimposition of androgen’s negative feedback by continuous i.v. testosterone infusions during ketoconazole treatment restores fully the regularity of LH release patterns (38). Analogously for the thyrotropic axis, primary hypothyroidism with deficient thyroxine negative-feedback significantly disrupts TSH secretion patterns, as quantified by higher ApEn of 24-h serum TSH concentration profiles (39). In a third feedback axis, viz. that of GH-IGF-I, short-term fasting with a resultant fall in plasma IGF-I concentrations calls forth a consistently elevated ApEn of 24-h GH release in men and women, which signifies disruption of the orderliness of another pituitary secretory process during feedback withdrawal (12, 40). Fourth, in men with primary gonadal failure, the pattern reproducibility of FSH release degenerates quantifiably in the face of testosterone feedback withdrawal, but is restored by androgen repletion (41). And, fifth, in endocrine tumors associated with acromegaly, Cushing’s disease, and hyperprolactinemia, the secretion patterns of respectively GH, ACTH, and prolactin, are prominently irregular (9). This is consistent with (but not proof of) unregulated tumoral hormone secretion sustained independently of normal feedforward and feedback controls (40, 42). Thus, pertinent statistical appraisal of both one-variable irregularity and two-variable asynchrony can potentially afford significant insights into altered network-level behavior within diverse biological feedback and feedforward control systems.

Overnight mean serum LH and total testosterone concentrations in the young and older male cohorts were statistically similar. However, so-called bioavailable testosterone concentrations are often reduced in aging individuals (24). The impact, if any, of this relative androgen deficiency that accompanies healthy aging in men on the CNS-neuroendocrine processes that coordinate synchronous LH-FSH, LH-prolactin, FSH-prolactin, and LH-NPT oscillatory patterns is not known. Evaluating healthy older men before and after testosterone administration in a physiological pattern and (young-adult) amount would be required to clarify this query. Moreover, because the activities of multiple specific neurotransmitter pathways (e.g. noradrenergic, cholinergic, dopaminergic, glutaminergic, etc.) change in aging (43, 44), future studies with clinically suitable receptor specific neuromodulators should help to define (putative) neurochemical mechanisms that underlie inferred age-associated loss of central synchronous control of the (male) reproductive axis.

For both scientific and clinical reasons, we would highlight that the network aspects (paired-signal disruption) of age-related changes observed here in older men are more pronounced than univariate (single-process) changes. Our corresponding proposition of multi-nodal disruption in aging has evident implications to clinical theory and intervention strategies. For example, in relation to male (or female) sexual dysfunction and loss of libido in aging, attempts to restore capabilities toward those anticipated in younger life may require primarily restoration of axis synchronicity, rather than sex-hormone supplementation or local therapy alone. That is, if a clinical disorder is determined by an overall system decoupling, then reestablishment of full network coordination (rather than replacing a single target-hormone deficiency) may be optimal for recovery of full physiological function. In this regard, the exploration of selective neuromodulators to restore (synchronous) CNS-hypothalamus-pituitary regulatory control, while simultaneously reconstituting CNS sleep/activity coupling to relevant neuroendocrine output of one or more axes (e.g. LH, GH, prolactin), could therefore have clinical merit in therapies of aging.

Complementary to our postulated notion of hypothalamic neural-network aging in the healthy human male are the decrements in LH-FSH irregularity differences recognized recently in older men as well as in women (3) and the proposed CNS regulatory disturbances in the reproductively aging rodent (33, 44, 45). Thus, aging-associated alterations in interacting hypothalamic networks may constitute a more unifying aging mechanism subserving (progressive) reproductive failure in both the human and experimental animal. The possible extension of this postulate to other (e.g. nonreproductive) neuroendocrine axes and/or other (non-neuroendocrine) biological feedback-control systems in aging will be pertinent to evaluate further.


    Acknowledgments
 
We thank Patsy Craig for her skillful preparation of the manuscript; Paula P. Azimi for the data analysis, management, and graphics; Brenda Grisso for performance of the chemiluminescence assays; and Sandra Jackson and the expert nursing staff at the University of Virginia General Clinical Research Center for conduct of the research protocols.


    Footnotes
 
1 This work was supported in part by NIH Grant MO1 RR00847 (to the General Clinical Research Center of the University of Virginia Health Sciences Center), Research Career Development Award 1-KO4-HD-00634 (to J.D.V.), National Science Foundation Center for Biological Timing (NSF Grant DIR 89–20162), the NIH U-54 Specialized Cooperative Centers Program in Reproductive Research (HD-28934), Veterans Affairs Merit Review Research Program (T.M.), and NIH RO1 AG 14799–01 (J.D.V.). Back

Received December 30, 1998.

Revised June 9, 1999.

Accepted July 26, 1999.


    References
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 

  1. Pincus SM, Mulligan T, Iranmanesh A, Gheorghiu S, Godschalk M, Veldhuis JD. 1996 Older males secrete luteinizing hormone and testosterone more irregularly, and jointly more asynchronously, than younger males. Proc Natl Acad Sci USA. 93:14100–14105.[Abstract/Free Full Text]
  2. Veldhuis JD, Liem AY, South S, et al. 1995 Differential impact of age, sex-steroid hormones, and obesity on basal vs. pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assay. J Clin Endocrinol Metab. 80:3209–3222.[Abstract]
  3. Pincus SM, Veldhuis JD, Mulligan T, Iranmanesh A, Evans WS. 1997 Effects of age on the irregularity of LH and FSH serum concentrations in women and men. Am J Physiol. 273:E989–E995.
  4. Meneilly GS, Ryan AS, Veldhuis JD, Elahi D. 1997 Increased disorderliness of basal insulin release, attenuated insulin secretory burst mass, and reduced ultradian rhythmicity of insulin secretion in older individuals. J Clin Endocrinol Metab. 82:4088–4093.[Abstract/Free Full Text]
  5. Mulligan T, Iranmanesh A, Johnson ML, Straume M, Veldhuis JD. 1997 Aging alters feedforward and feedback linkages between LH and testosterone in healthy men. Am J Physiol. 42:R1407–R1413.
  6. Veldhuis JD, King JC, Urban RJ, et al. 1987 Operating characteristics of the male hypothalamo-pituitary-gonadal axis: pulsatile release of testosterone and follicle-stimulating hormone and their temporal coupling with luteinizing hormone. J Clin Endocrinol Metab. 65:929–941.[Abstract]
  7. Foresta C, Bordon P, Rossato M, Mioni R, Veldhuis JD. 1997 Specific linkages among luteinizing hormone, follicle stimulating hormone, and testosterone release in the peripheral blood and human spermatic vein: evidence for both positive (feed-forward) and negative (feedback) within-axis regulation. J Clin Endocrinol Metab. 82:3040–3046.[Abstract/Free Full Text]
  8. Pincus SM. 1995 Quantifying complexity and regularity of neurobiological systems. Meth Neurosci. 28:336–363.
  9. Veldhuis JD, Pincus SM. 1999 Orderliness of hormone release patterns: a complementary measure to conventional pulsatile and circadian analyses. Eur J Endocrinol. 138:358–362.
  10. Mulligan T, Iranmanesh A, Gheorghiu S, Godschalk M, Veldhuis JD. 1995 Amplified nocturnal luteinizing hormone (LH) secretory burst frequency with selective attenuation of pulsatile (but not basal) testosterone secretion in healthy aged men: possible Leydig cell desensitization to endogenous LH signaling–a clinical research center study. J Clin Endocrinol Metab. 80:3025–3031.[Abstract/Free Full Text]
  11. Veldhuis JD, Urban RJ, Lizarralde G, Johnson ML, Iranmanesh A. 1992 Attenuation of luteinizing hormone secretory burst amplitude is a proximate basis for the hypoandrogenism of healthy aging in men. J Clin Endocrinol Metab. 75:52–58.
  12. Mulligan TM, Iranmanesh A, Veldhuis JD. 1998 Failed restitution of Leydig cell testosterone secretion despite full normalization of pulsatile release by two weeks of exogenous pulsatile GnRH pump/infusion therapy in older men. Presented at the 80th Annual Meeting of The Endocrine Society, New Orleans, Louisiana, June 24–27, 1998.
  13. Deslypere JP, Kaufman JM, Vermeulen T, Vogelaers D, Vandalem JL, Vermeulen A. 1987 Influence of age on pulsatile luteinizing hormone release and responsiveness of the gonadotrophs to sex hormone feedback in men. J Clin Endocrinol Metab. 64:68–73.[Abstract]
  14. Schiavi RC, White D, Mandeli J, Schreiner-Engel P. 1993 Hormones and nocturnal penile tumescence in healthy aging men. Arch Sex Behav. 22:207–215.[CrossRef][Medline]
  15. Pincus SM, Singer BH. 1996 Randomness and degrees of irregularity. Proc Natl Acad Sci USA. 93:2083–2088.[Abstract/Free Full Text]
  16. Pincus SM. 1991 Approximate entropy as a measure of system complexity. Proc Natl Acad Sci USA. 88:2297–2301.[Abstract/Free Full Text]
  17. Iranmanesh A, Mulligan T, Veldhuis JD. 1999 Mechanisms subserving the physiological nocturnal relative hypoprolactinemia of healthy older men: dual decline in prolactin secretory burst mass and basal release with preservation of pulse duration, frequency, and interpulse interval. J Clin Endocrinol Metab. 84:1083–1090.[Abstract/Free Full Text]
  18. Veldhuis JD, Johnson ML. 1992 Deconvolution analysis of hormone data. Meth Enzymol. 210:539–575.[Medline]
  19. Veldhuis JD, Fraioli F, Rogol AD, Dufau ML. 1986 Metabolic clearance of biologically active luteinizing hormone in man. J Clin Invest. 77:1122–1128.
  20. Pincus SM, Huang WM. 1992 Approximate entropy: statistical properties and applications. Commun Statist The Meth. 21:3061–3077.
  21. Veldhuis JD, Carlson ML, Johnson ML. 1987 The pituitary gland secretes in bursts: appraising the nature of glandular secretory impulses by simultaneous multiple-parameter deconvolution of plasma hormone concentrations. Proc Natl Acad Sci USA. 84:7686–7690.[Abstract/Free Full Text]
  22. Nahoul K, Roger M. 1990 Age-related decline of plasma bioavailable testosterone in adult men. J Ster Biochem. 35:293–299.[CrossRef][Medline]
  23. Longcope C, Goldfield SR, Brambilla DJ, McKinlay J. 1990 Androgens, estrogens, and sex hormone-binding globulin in middle-aged men. J Clin Endocrinol Metab. 71:1442–1446.[Abstract]
  24. Morley JE, Kaiser FE, Perry 3rd HM, et al. 1997 Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metab Clin Exp. 46:410–413.
  25. Winters SJ, Troen P. 1982 Episodic luteinizing hormone (LH) secretion and the response of LH and follicle-stimulating hormone to LH-releasing hormone in aged men: evidence for coexistent primary testicular insufficiency and an impairment in gonadotropin secretion. J Clin Endocrinol Metab. 55:560–565.[Abstract]
  26. Veldhuis JD, Iranmanesh A, Samojlik E, Urban RJ. 1997 Differential sex-steroid negative feedback regulation of pulsatile follicle-stimulating hormone secretion in healthy older men: deconvolution analysis and steady state sex steroid hormone infusions in frequently sampled healthy older individuals. J Clin Endocrinol Metab. 82:1248–1254.[Abstract/Free Full Text]
  27. Gray A, Feldman HS, McKinlay JB, Longcope C. 1991 Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 73:1016–1025.[Abstract]
  28. Blackman MR, Weintraub BD, Rosen SW, Harman SM. 1988 Comparison of the effects of lung cancer, benign lung disease, and normal aging on pituitary-gonadal function in men. J Clin Endocrinol Metab. 66:88–95.[Abstract]
  29. Gray A, Berlin JA, McKinlay JB, Longcope C. 1991 An examination of research design effects on the association of testosterone and male aging: results of a meta-analysis. J Clin Epidemiol. 44:671–684.[CrossRef][Medline]
  30. Bremner WJ, Vitiello MV, Prinz PN. 1983 Loss of circadian rhythmicity in blood testosterone levels with aging in normal men. J Clin Endocrinol Metab. 56:1278–1281.[Abstract]
  31. Merino G, Carranza-Lira S. 1995 Semen characteristics, endocrine profiles, and testicular biopsies of infertile men of different ages. Arch Androl. 35:219–224.[Medline]
  32. Braund W, Roeger DC, Judd SJ. 1984 Synchronous secretion of luteinizing hormone and prolactin in the human luteal phase: neuroendocrine mechanisms. J Clin Endocrinol Metab. 58:293–297.[Abstract]
  33. Romero MT, Silverman AJ, Wise PM, Witkin JW. 1994 Ultrastructural changes in gonadotropin-releasing hormone neurons as a function of age and ovariectomy in rats. Neuroscience. 58:217–225.[CrossRef][Medline]
  34. Tougard C, Tixier-Vidal A. 1988 Lactotropes and gonadotropes. In: Knobil E, Neill JC, Ewing LL, Greenwald HS, Mardert CL, Pfaff DW, eds. The Physiology of Reproduction. New York: Raven Press; 1305–1333.
  35. Begot M, Hemming FJ, Dubois PM, Combarnous Y, Aubert ML. 1984 Induction of pituitary lactotrope differentiation by luteinizing hormone alpha subunit. Science. 226:566–568.[Abstract/Free Full Text]
  36. Davidson JM, Chen JJ, Crapo L, Gray GD, Greenleaf WJ, Catania JA. 1983 Hormonal changes and sexual function in aging men. J Clin Endocrinol Metab. 57:71.[Abstract]
  37. Urban RJ, Evans WS, Rogol AD, Kaiser DL, Johnson ML, Veldhuis JD. 1988 Contemporary aspects of discrete peak detection algorithms. I. The paradigm of the luteinizing hormone pulse signal in men. Endocr Rev. 9:3–37.[Medline]
  38. Veldhuis JD, Zwart AD, Iranmanesh A. 1997 Neuroendocrine mechanisms by which selective Leydig-cell castration unleashes increased pulsatile LH release in the human: an experimental paradigm of short-term ketoconazole-induced hypoandrogenemia and deconvolution-estimated LH secretory enhancement. Am J Physiol. 272:R464–R474.
  39. Veldhuis JD, Iranmanesh A, Pincus SM. 1996 Reduction of intrinsic negative feedback regulation of neuroendocrine axes increases the approximate entroy (serial irregularity) of the pituitary hormone release process for TSH, GH, and LH. Presented at the Society for Neuroscience Meeting, Washington, D.C., November 16–21, 1996.
  40. Hartman ML, Pincus SM, Johnson ML, Matthews DH, Faunt LM, Vance ML, Thorner MO, Veldhuis JD. 1994 Enhanced basal and disorderly growth hormone secretion distinguish acromegalic from normal pulsatile growth hormone release. J Clin Invest. 94:1277–1288.
  41. Veldhuis JD, Iranmanesh A, Urban RJ. 1997 Primary gonadal failure in men selectively amplifies the mass of follicle stimulating hormone (FSH) secreted per burst and increases the disorderliness of FSH release: reversibility with testosterone replacement. Internat J Androl. 20:297–305.
  42. Van den Berghe G, Pincus SM, Frolich M, Veldhuis JD, Roelfsema F. 1998 Reduced disorderliness of growth hormone release in biochemically inactive acromegaly after pituitary surgery. Eur J Endocrinol. 138:164–169.[Abstract]
  43. Meites J. 1991 Role of hypothalamic catecholamines in aging processes. Acta Endocrinol. 125:98–106.
  44. Sortino MA, Aleppo G, Scapagnini U, Canonico PL. 1996 Different responses of gonadotropin-releasing hormone (GnRH) release to glutamate receptor agonists during aging. Brain Res Bull. 41:359–362.[CrossRef][Medline]
  45. Roselli CE, Thornton JE, Chambers KC. 1993 Age-related deficits in brain estrogen receptors and sexual behavior of male rats. Behav Neurosci. 107:202–209.[CrossRef][Medline]



This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
P. Y. Liu, P. Y. Takahashi, P. D. Roebuck, and J. D. Veldhuis
Age or Factors Associated with Aging Attenuate Testosterone's Concentration-Dependent Enhancement of the Regularity of Luteinizing Hormone Secretion in Healthy Men
J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 4077 - 4084.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
P. Y. Liu, S. M. Pincus, P. Y. Takahashi, P. D. Roebuck, A. Iranmanesh, D. M. Keenan, and J. D. Veldhuis
Aging attenuates both the regularity and joint synchrony of LH and testosterone secretion in normal men: analyses via a model of graded GnRH receptor blockade
Am J Physiol Endocrinol Metab, January 1, 2006; 290(1): E34 - E41.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Y. Liu, P. Y. Takahashi, P. D. Roebuck, A. Iranmanesh, and J. D. Veldhuis
Aging in Healthy Men Impairs Recombinant Human Luteinizing Hormone (LH)-Stimulated Testosterone Secretion Monitored under a Two-Day Intravenous Pulsatile LH Clamp
J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5544 - 5550.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
P. Y. Liu, P. Y. Takahashi, P. D. Roebuck, A. Iranmanesh, and J. D. Veldhuis
Age-specific changes in the regulation of LH-dependent testosterone secretion: assessing responsiveness to varying endogenous gonadotropin output in normal men
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2005; 289(3): R721 - R728.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Iranmanesh and J. D. Veldhuis
Combined Inhibition of Types I and II 5 {alpha}-Reductase Selectively Augments the Basal (Nonpulsatile) Mode of Testosterone Secretion in Young Men
J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4232 - 4237.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
R. G. Smith, L. Betancourt, and Y. Sun
Molecular Endocrinology and Physiology of the Aging Central Nervous System
Endocr. Rev., April 1, 2005; 26(2): 203 - 250.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. D. Veldhuis, N. J. D. Veldhuis, D. M. Keenan, and A. Iranmanesh
Age diminishes the testicular steroidogenic response to repeated intravenous pulses of recombinant human LH during acute GnRH-receptor blockade in healthy men
Am J Physiol Endocrinol Metab, April 1, 2005; 288(4): E775 - E781.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
P. Y. Liu, S. M. Pincus, D. M. Keenan, F. Roelfsema, and J. D. Veldhuis
Analysis of bidirectional pattern synchrony of concentration-secretion pairs: implementation in the human testicular and adrenal axes
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2005; 288(2): R440 - R446.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. D. Veldhuis, A. Iranmanesh, and T. Mulligan
Age and Testosterone Feedback Jointly Control the Dose-Dependent Actions of Gonadotropin-Releasing Hormone in Healthy Men
J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 302 - 309.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. D. Veldhuis and A. Iranmanesh
Pulsatile Intravenous Infusion of Recombinant Human Luteinizing Hormone under Acute Gonadotropin-Releasing Hormone Receptor Blockade Reconstitutes Testosterone Secretion in Young Men
J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4474 - 4479.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. De Rosa, S. Zarrilli, G. Vitale, C. Di Somma, F. Orio, L. Tauchmanova', G. Lombardi, and A. Colao
Six Months of Treatment with Cabergoline Restores Sexual Potency in Hyperprolactinemic Males: An Open Longitudinal Study Monitoring Nocturnal Penile Tumescence
J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 621 - 625.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Charmandari, S. M. Pincus, D. R. Matthews, A. Johnston, C. G. D. Brook, and P. C. Hindmarsh
Oral Hydrocortisone Administration in Children with Classic 21-Hydroxylase Deficiency Leads to More Synchronous Joint GH and Cortisol Secretion
J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2238 - 2244.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
A. M. Matsumoto
Andropause: Clinical Implications of the Decline in Serum Testosterone Levels With Aging in Men
J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2002; 57(2): M76 - 99.
[Full Text]


Home page
EndocrinologyHome page
I. Clarke, L. Moore, and J. Veldhuis
Intensive Direct Cavernous Sinus Sampling Identifies High-Frequency, Nearly Random Patterns of FSH Secretion in Ovariectomized Ewes: Combined Appraisal by RIA and Bioassay
Endocrinology, January 1, 2002; 143(1): 117 - 129.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. D. Veldhuis, M. L. Johnson, O. L. Veldhuis, M. Straume, and S. M. Pincus
Impact of pulsatility on the ensemble orderliness (approximate entropy) of neurohormone secretion
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2001; 281(6): R1975 - R1985.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. D. Veldhuis, A. Iranmanesh, D. Naftolowitz, N. Tatham, F. Cassidy, and B. J. Carroll
Corticotropin Secretory Dynamics in Humans under Low Glucocorticoid Feedback
J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5554 - 5563.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. D. Veldhuis, S. M. Pincus, M. C. Garcia-Rudaz, M. G. Ropelato, M. E. Escobar, and M. Barontini
Disruption of the Synchronous Secretion of Leptin, LH, and Ovarian Androgens in Nonobese Adolescents with the Polycystic Ovarian Syndrome
J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3772 - 3778.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. A. Gusenoff, S. M. Harman, J. D. Veldhuis, J. J. Jayme, C. St. Clair, T. Munzer, C. Christmas, K. G. O'Connor, T. E. Stevens, M. F. Bellantoni, et al.
Cortisol and GH secretory dynamics, and their interrelationships, in healthy aged women and men
Am J Physiol Endocrinol Metab, April 1, 2001; 280(4): E616 - E625.
[Abstract] [Full Text] [PDF]


Home page